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A B S T R A C T
Background
Blood for transfusion may become contaminated at any point between collection and transfusion and may result in bacteraemia (the
presence of bacteria in the blood), severe illness or even death for the blood recipient. Donor arm skin is one potential source of
blood contamination, so it is usual to cleanse the skin with an antiseptic before blood donation. One-step and two-step alcohol based
antiseptic regimens are both commonly advocated but there is uncertainty as to which is most effective.
Objectives
To assess the effects of cleansing the skin of blood donors with alcohol in a one-step compared with alcohol in a two-step procedure to
prevent contamination of collected blood or bacteraemia in the recipient.
Search methods
For this first update we searched the Cochrane Wounds Group Specialised Register (searched 28 January 2010); The Cochrane Central
Register of Controlled Trials (CENTRAL) The Cochrane Library 2011, Issue 1; Ovid MEDLINE (2008 to January Week 2 2011);
Ovid MEDLINE (In-Process & Other Non-Indexed Citations January 25, 2011); Ovid EMBASE ( 2008 to 2011 Week 01); and
EBSCO CINAHL ( 2008 to 28 January 2011).
Selection criteria
All randomised trials (RCTs) comparing alcohol based donor skin cleansing in a one-step versus a two-step process that includes alcohol
and any other antiseptic for pre-venepuncture skin cleansing were considered. Quasi randomised trials were to have been considered
in the absence of RCTs.
Data collection and analysis
Two review authors independently assessed studies for inclusion.
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Main results
No studies (RCTs or quasi RCTs) met the inclusion criteria.
Authors’ conclusions
We did not identify any eligible studies for inclusion in this review. It is therefore unclear whether a two-step, alcohol followed by
antiseptic skin cleansing process prior to blood donation confers any reduction in the risk of blood contamination or bacteraemia in
blood recipients, or conversely whether a one-step process increases risk above that associated with a two-step process.
P L A I N L A N G U A G E S U M M A R Y
Alcohol, with or without an antiseptic, for preparing the skin before blood collection, to prevent bacteraemia or contamination
of blood for transfusion.
When blood is collected from blood donors for transfusion it may become contaminated during collection, storage or transfusion.
Blood contamination can cause bacteraemia (the presence of bacteria in the blood), severe illness or even death in the blood recipient.
When blood is being taken from donors, the skin on the arm of the donor is one potential source of contamination, so it is usual to
cleanse the arm with an antiseptic first, and both one-step and two-step alcohol based regimens are commonly used, however there is
uncertainty about which regimen is the most effective for reducing the microbial load (the number of microscopic bacterial organisms)
on the donor arm. We looked for studies that compared the use of alcohol alone versus the use of alcohol followed by another antiseptic
to clean the arm before the needle is inserted to draw blood, but we did not find any relevant studies. It is currently unclear whether
donor skin cleansing with a one-step alcohol based regimen reduces the risk of blood contamination compared with a two-step alcohol
based regimen during blood donation.
B A C K G R O U N D
Complications associated with the infusion of blood and blood-
related products have reduced in recent years, due to considerable
advances in detecting transfusion-related viral pathogens, such as
human immunodeficiency virus (HIV) and hepatitis C andB virus
(HCV and HBV). In contrast, bacteraemia, resulting from bac-
terial contamination of blood products continues to be an ongo-
ing problem (Sandler 2003; Wagner 2004). Exogenous contami-
nation of donor blood may occur at any point during collection,
storage and transfusion (McDonald 2001). One of the sources of
contamination is thought to be the donor’s skin, as a result of in-
adequate skin cleansing (de Korte 2006; McDonald 2006).
Description of the condition
Bacteraemia, or the presence of bacteria in the blood, is a poten-
tially fatal condition. It is associated with high rates of morbidity
(Hakim 2007; Sligl 2006). Microorganisms may enter the blood
stream through almost any organ (for example the lungs following
pneumonia), through a surgical site, or via an implanted device
such as an intravenous catheter. Prognosis is related to the viru-
lence of the infective organism, severity of the sepsis at diagnosis
and the underlying health of the patient (Herchline 1997). Al-
though the aetiology of bacteraemia is often difficult to identify,
transfusion-transmitted infection is a rare cause. The incidence
of bacterial transmission through donated blood is estimated at
between 1 per 100,000 and 1 per 1,000,000 units for packed red
blood cells, and between 1 per 900 and 1 per 100,000 units for
platelets (Walther-Wenke 2008). Fatalities are associated with 1
in 8,000,000 red cell units and 1 in 50,000 to 500,000 white
cell units (Wagner 2004). The reason for higher rates in platelet
transfusion is thought to be because frozen platelets are thawed
and stored at room temperature before infusion and if they are not
used immediately there is an opportunity for any organisms that
may be present to multiply before the product is transfused. Fur-
ther reduction of infection rates depends on ensuring that blood
for transfusion is free of contaminants. One way of achieving this
is through careful preparation and cleansing of the donor’s skin at
the collection site.
Description of the intervention
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There is no standard method for cleansing the site on the blood
donor’s skin from which the blood will be taken (generally the
cubital fossa, or the inner aspect of the elbow). However, alcohol,
followed by an application of povidone iodine has been tradition-
ally used (Shahar 1990; Kiyoyama 2009). Consequently, the in-
terventions of interest for this review are skin cleansing with alco-
hol (usually 70% isopropyl alcohol) for skin preparation in a one-
step process, compared with a two-step process involving alcohol
followed by povidone iodine or other antiseptic solution. Antisep-
tics are antimicrobial substances that are applied to living tissue
or skin to reduce the possibility of infection, sepsis or putrefac-
tion. They should generally be distinguished from antibiotics that
destroy bacteria within the body, and from disinfectants, which
destroy microorganisms found on non-living objects. Alcohol is
widely used prior to venepuncture and is available from a number
of manufacturers as easy-to-use disinfection wipes. Isopropyl al-
cohol is a flammable, colourless liquid; also known as 2-propanol
(MSDS 2006).
How the intervention might work
Alcohol killsmost bacteria and fungi by acting on lipid and protein
components of the cell. It is less effective against viruses (Adams
2007). Isopropyl alcohol has some advantages over other products
because it requires a shorter contact time to achieve antisepsis.
For example some two-step procedures take up to two minutes to
perform,which is considered too long for some bloodbank services
(McDonald 2006). Antiseptics are toxic to living tissues as well
as bacterial cells, some antiseptics are true germicides, capable of
destroyingmicrobes (bacteriocidal), whilst others are bacteriostatic
and only prevent or inhibit their growth (Morgan 1993).
Why it is important to do this review
Although a range of antiseptics has been used to cleanse the skin of
the donor arm, a two-step process, including alcohol and iodine is
widely used (Kiyoyama 2009; Shahar 1990). The effectiveness of
this regimen, and other forms of cleansing has been evaluated in a
number of studies by measuring the microbial load on the donor
arm (Cid 2003; Follea 1997; Goldman 1997; McDonald 2001;
Wong 2004) and any contamination of platelet concentrates de
Korte 2006; Lee 2002) however it remains unclear whether iso-
propyl alcohol alone is as effective as alcohol plus povidone iodine
(or any other antiseptic) in preventing the clinical consequences
of contaminated blood. This review question was brought to us by
the World Health Organisation (WHO) and a scoping search did
not identify any existing systematic review which had previously
addressed this question.
O B J E C T I V E S
To assess the effects of cleansing the donor arm with alcohol in
a one-step regimen compared with a two-step regimen including
alcohol followed by any other antiseptic to prevent donor blood
contamination or recipient bacteraemia.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs) comparing a one-step al-
cohol regimen with any two-step regimen that includes alcohol
followed by another antiseptic for pre-venepuncture skin cleans-
ing were considered. Cluster randomised trials and crossover trials
were also eligible for inclusion. Quasi randomised trials were to
have been considered in the absence of RCTs.
Types of participants
Studies enrolling people of any age and in any setting, having
venepuncture and blood collection were eligible, irrespective of
whether the venepuncture was for the purpose of blood donation.
Studies should also include follow up from the recipients of the
donated blood in order to measure outcomes occurring in the
recipient.
Types of interventions
Studies which compared one-step donor skin cleansing with al-
cohol (any concentration or application method) with a two-
step method which involved alcohol (any strength or application
method) followed by any other antiseptic (any concentration or
application method) were eligible.
Types of outcome measures
At least one of the primary outcomes was to have been reported
for the study to be considered for inclusion in the review.
Primary outcomes
• Bacteraemia in the blood recipient (the presence of bacteria
in the blood stream) as measured by blood culture.
• Blood product contamination (blood products include
whole blood, platelets, red blood cells or any other product
derived from the blood collection) at any time between collection
and transfusion as detected most commonly by blood culture.
Proxy outcome measures, such as skin contamination or skin
colonisation, were not considered for several reasons. Namely, any
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antiseptic will reduce levels ofmicroflora on the skin and swabbing
skin for bacteria is really a ’sampling procedure’ which is subject
to inconsistencies in sampling. In addition, a positive skin culture
does not automatically mean that the blood collected for transfu-
sion will be positive for bacteria (in the same way that a positive
skin culture before surgery does not mean the person will develop
a surgical site infection).
Secondary outcomes
• Death of the blood recipient, attributed to the transfusion.
• Any adverse effects in the blood recipient associated with
the transfusion. This may include sepsis (a grouping of signs
such as fever, chills, or hypotension), septic shock (severe
disturbances of temperature, respiration, heart rate or white
blood cell count) or multiple organ dysfunction syndrome
(altered organ function in a severely ill patient that requires
medical intervention to prevent death).
Search methods for identification of studies
The search methods used in the original version of this review can
be found in Appendix 1.
Electronic searches
For this first update we searched the following databases:
• Cochrane Wounds Group Specialised Register (searched 28
January 2010);
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2011, Issue 1);
• Ovid MEDLINE (2008 to January Week 2 2011);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations January 25, 2011);
• Ovid EMBASE (2008 to 2011 Week 01);
• EBSCO CINAHL (2008 to 28 January 2011)
The Cochrane Central Register of Controlled Trials (CENTRAL)
was searched using the following strategy:
#1 MeSH descriptor Blood Specimen Collection explode all trees
#2 MeSH descriptor Blood Transfusion explode all trees
#3 MeSH descriptor Blood Donors explode all trees
#4 (blood NEXT collection*) or (blood NEXT donor*) or (blood
NEXT donation*):ti,ab,kw
#5 (collection NEAR/1 blood) or (donation NEAR/1 blood):
ti,ab,kw
#6 ven*puncture NEXT site*:ti,ab,kw
#7 (#1 OR #2 OR #3 OR #4 OR #5 OR #6)
#8 MeSH descriptor Antisepsis explode all trees
#9MeSH descriptor Anti-Infective Agents, Local explode all trees
#10 MeSH descriptor Iodine Compounds explode all trees
#11 MeSH descriptor Povidone-Iodine explode all trees
#12 MeSH descriptor Alcohols explode all trees
#13 MeSH descriptor Disinfectants explode all trees
#14 MeSH descriptor Disinfection explode all trees
#15 skin NEXT preparation:ti,ab,kw
#16 disinfect*:ti,ab,kw
#17 (“alcohol” or “alcohols” or iodine or povidone-iodine or
chlorhexidine):ti,ab,kw
#18 (#8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR
#15 OR #16 OR #17)
#19 (#7 AND #18)
The search strategies for Ovid MEDLINE, Ovid EMBASE and
EBSCO CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4 respectively. The Ovid MEDLINE search was com-
binedwith theCochraneHighly Sensitive Search Strategy for iden-
tifying randomised trials inMEDLINE: sensitivity- and precision-
maximizing version (2008 revision) (Lefebvre 2009). The Ovid
EMBASE and EBSCO CINAHL searches were combined with
the trial filters developed by the Scottish Intercollegiate Guidelines
Network (SIGN 2009). There was no restriction on the basis of
date or language of publication.
Searching other resources
Reference lists of articles retrieved in full were searched.
Data collection and analysis
Selection of studies
Titles and abstracts identified through the search process were in-
dependently reviewed by two review authors. Full reports of all
potentially relevant studies were retrieved for further assessment
of eligibility based on the inclusion criteria. Differences of opin-
ion were settled by consensus or referral to a third review author.
There was no blinding to study authorship when we did these
assessments.
Data extraction and management
We had planned to extract the following data, where available (to
be extracted by one review author and checked by a second review
author):
• details of the trial/study (first author, year of publication,
journal, publication status, period);
• setting and country of study;
• source of funding;
• inclusion and exclusion criteria;
• baseline characteristics of participants (age, sex);
• aspects of morbidity of the blood recipients, e.g. predictors
of susceptibility to bacteraemia;
• number of participants in each arm of the trial;
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• description of intervention (type, duration);
• description of control intervention (type, duration);
• details and duration of follow up;
• primary and secondary outcomes (by group);
• design / methodological quality data as per risk of bias
criteria;
• unit of randomisation (where relevant);
• unit of analysis;
• results and primary statistical analysis.
Assessment of risk of bias in included studies
Two review authors were to independently assess study risk of bias
using the Cochrane Collaboration tool (Higgins 2009b).This tool
addresses six specific domains, namely sequence generation, al-
location concealment, blinding, incomplete outcome data, selec-
tive outcome reporting and other issues (e.g. co-interventions)(see
Appendix 5 for details of criteria on which the judgements were
to have been based). Blinding and completeness of outcome data
would have been assessed for each outcome separately and we had
planned to complete a risk of bias table for each eligible study.
We planned to contact investigators of included studies to resolve
any ambiguities. We also planned to include data from duplicate
publications only once, but to retrieve all publications pertaining
to a single study to enable full data extraction and risk of bias
quality assessment.
For any eligible study, we planned to present assessment of risk
of bias using a ’risk of bias summary figure’, which presents the
judgments in a cross-tabulation of study by entry. This display
of internal validity indicates the weight the reader may give the
results of each study.
Measures of treatment effect
For individual trials, effect measures for categorical outcomes
(e.g. rates of bacteraemia) would have included relative risk (RR)
with its 95% confidence interval (CI). For continuous outcomes,
we planned to use the mean difference (MD) or, if the scale of
measurement differed across trials, standardized mean difference
(SMD), each with its 95% CI. For any meta-analyses (see below),
for categorical outcomes the typical estimates of RR with their
95%CIwould have been calculated; and for continuous outcomes
the weighted mean difference (WMD) or a summary estimate for
SMD, each with its 95% CI, would have been calculated.
We planned to analyse data using The Cochrane Collaboration’s
Review Manager 5 software.
Dealing with missing data
If outcome data had remained missing despite our attempts to
obtain complete outcome data from authors, we would have per-
formed an available-case analysis, based on the numbers of pa-
tients for whom outcome data were known. If standard deviations
were missing, we would have imputed them from other studies
or, where possible, computed them from standard errors using the
formula SD = SE x
√
N , where these were available (Higgins
2009c).
Assessment of heterogeneity
Heterogeneity would have been assessed visually and by using the
chi-squared statistic with significance being set at p < 0.10. In ad-
dition, the degree of heterogeneity would have been investigated
by calculating the I2 statistic (Deeks 2008). If evidence of signifi-
cant heterogeneity had been identified (I2 >50%), we would have
explored potential causes and a random-effects approach to the
analysis would have been used if a meta-analysis had been appro-
priate.
Assessment of reporting biases
Reporting bias would have been assessed using guidelines in the
Cochrane Handbook for Systematic Reviews of Interventions (
Sterne 2008).
Data synthesis
Where appropriate, results of comparable trials would have been
pooled and the pooled estimate together with its 95% CI would
have been reported. We planned to conduct a narrative review of
eligible studies if statistical synthesis of data from more than one
study was not possible or considered not appropriate.
Subgroup analysis and investigation of heterogeneity
Weplanned to analyse potential sources of heterogeneity using the
following subgroup analysis: concealment of allocation (adequate
versus not reported).
Sensitivity analysis
We planned to undertake a sensitivity analysis to explore the effect
of excluding studies where concealment of allocation was unclear
R E S U L T S
Description of studies
See: Characteristics of excluded studies.
We did not find any randomised or quasi-randomised controlled
trials that met the inclusion criteria.
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Results of the search
Our initial search identified 457 citations of which 19were consid-
ered potentially relevant. Full copies of these papers were obtained
and reviewed independently by two review authors, however, none
met the inclusion criteria. The search for the first update identi-
fied 90 citations none of which were relevant, 3 further citations
were identified through internet searching but did not meet the
inclusion criteria and were added to the Table of Excluded studies.
Included studies
No studies were included.
Excluded studies
The Table: Characteristics of excluded studies contains reasons for
excluding 22 potentially eligible studies. In summary, two cita-
tions were for unsystematic literature reviews (Blajchman 2004;
Wendel 2002) eight trials did not compare the eligible interven-
tions (Calfee 2002; Choudhuri 1990; Little 1999; Mimoz 1999;
Schifman 1993; Sutton 1999; Suwanpimolkul 2008; Trautner
2002). Eight studies were not randomised or quasi randomised
controlled trials (de Korte 2006; Goldman 1997; Kiyoyama 2009;
Lee 2002; McDonald 2006; Pleasant 1994; Shahar 1990; Wong
2004). One study examined techniques for quantifying bacte-
rial reduction (Follea 1997) and three were neither randomised
controlled trials nor did they address any of the reviews’ pri-
mary or secondary outcomes (Benjamin 2010; McDonald 2010;
Ramirez-Arcos 2010).
Risk of bias in included studies
No studies were included.
Effects of interventions
We did not identify any eligible randomised or quasi randomised
controlled trials, nor were we able to identify any ongoing trials.
D I S C U S S I O N
We have been unable to identify any trials addressing the effec-
tiveness of alcohol alone compared with alcohol followed by any
other antiseptic to prevent bacteraemia from transfused blood or
blood products. This may be because infusion related bacteraemia
is a relatively rare event and very large trials would be needed
to investigate the effect of donor-arm cleansing. Sepsis rates for
platelet transfusions are around 1:50,000 and for red cell trans-
fusions around 1:500,000 (Sandler 2003). Therefore mounting a
trial large enough to detect differences in clinical outcomes, based
on products used for arm cleansing, would be prohibitively expen-
sive and lengthy.
Because of this, surrogate measures, such as contamination of
stored blood have been used to evaluate antisepsis efficacy. How-
ever, again, we found no trials that compared alcohol alone with
alcohol followed by any other antiseptic for cleansing the donor
skin. A number of studies used the surrogate outcome of post-
cleansing skin microbial load at the venepuncture site however we
excluded such studies a priori on the grounds that this is a surro-
gate outcome of unproven validity; it is not known how skin con-
tamination relates to blood recipient outcomes. Moreover none of
these trials compared a one-step with a two-step cleansing process
(de Korte 2006; Follea 1997; Goldman 1997).
Whilst we did identify two studies that compared the effects of
the eligible interventions they were otherwise ineligible for impor-
tant methodological reasons and did not meet our pre-specified
study design eligibility criteria. The first compared blood culture
contamination following pre-venepuncture cleansing with 70%
alcohol for one minute followed by povidone iodine solution for
an additional minute with brief swabbing of the skin three to five
times with 70% alcohol. Patients who were suspected of having
bacteraemia had two blood samples taken; once using the two-
step method and once with the standard method. Unfortunately
it appeared from the report that the order in which the methods
were used was not randomised and samples may have been taken
from the same or a closely adjacent site with an unreported time
lapse between sampling. Of the 181 cultures tested in each group,
eight (4.4%) were positive in the two-step group compared with
six (3.3%) in the one-step preparation group (no statistically sig-
nificant difference) (Shahar 1990). The second study potentially
suffers from important selection bias in that the treatment groups
were in different settings as well as receiving different modes of
skin cleansing and compared blood culture contamination rates
between patients inwhomblood had been drawn in the emergency
department and who received a one-step 70% alcohol cleansing
with inpatients who received a two-step 70% alcohol followed by
povidone iodine procedure. Although there was a statistically sig-
nificant difference in positive culture rates in favour of the one
step process (189 (6.6%) positive cultures in the one-step group
versus 248 (8.9%) in the two step, alcohol plus iodine group (p
= 0.0015) (Kiyoyama 2009) this study was not eligible for inclu-
sion in the review due to the inherent risk of selection bias (inpa-
tients and emergency department patients may well be at different
levels of risk of positive blood culture). Thus whilst the authors
presented additional data to suggest that baseline positive blood
culture rates were similar between inpatients and emergency de-
partment patients the risk of selection bias remains and this study
was excluded (Kiyoyama 2009).
In conclusion there is currently no evidence of a difference in either
blood contamination or bacteraemia when donor skin is cleansed
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pre-venepuncture with a one-step alcohol based process or a two-
step alcohol plus antiseptic process. This lack of evidence for a
difference however results from a complete absence of research
and therefore a real difference cannot be discounted. Until better
evidence emerges, decisions about which mode of pre-blood do-
nation skin cleansing to use are likely to be driven by convenience
and cost. It is also important to note that arm cleansing is only one
of the points at which blood contamination may occur. Careful
collection and storage of blood and blood products, and systematic
surveillance to detect bacterial contamination can all contribute to
the safety of patients requiring blood transfusions. Eliminating all
bacteria from stored blood may not be possible. So, following rel-
evant clinical guidelines (for example UK BTS Guidelines 2005)
for collection and for detecting bacterial contamination in stored
blood, both at the time of collection and at the time of issue, may
be the most effective way of reducing infusion related bacteraemia
(Yomtovian 2006).
Summary of main results
Wedid not identify any eligible studies for inclusion in this review.
It is therefore unclear whether a two-step, alcohol followed by
antiseptic skin cleansing process prior to blood donation confers
any reduction in the risk of blood contamination or bacteraemia
in blood recipients (or conversely whether a one-step process in-
creases risk above that associated with a two-step process).
Potential biases in the review process
Biases in the review process were minimised as far as possible by
adhering to the guidance provided by the Cochrane Handbook
(Higgins 2009a). We believe that publication bias is unlikely in
this case; whilst no trials met the inclusion criteria , this is probably
due to the difficulty and expense associated with mounting a trial
large enough to answer the question.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We did not find any eligible randomised or quasi randomised
controlled trials. Until further research emerges, decisions about
which mode of pre-blood donation skin cleansing to use are likely
to be driven by convenience and cost. It is also important to note
that arm cleansing is only one of the points at which blood con-
tamination may occur.
Implications for research
Cleansing the donor skin before taking blood for transfusion is
important, but conducting a trial to compare the effects of using
specific antiseptics on bacteraemia rates would be logistically dif-
ficult given the relatively rare event rate. It may be possible to es-
timate the effects of disinfecting with alcohol alone versus alcohol
plus other antiseptics on blood contamination rates but this would
still require very large sample sizes to detect clinically important
differences. Alternatively, high quality observational studies may
provide additional information to guide practice. A future com-
prehensive evidence synthesis that summarised the evidence for
all competing alternative approaches to pre-blood donation skin
cleansing would be worthwhile.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Benjamin 2010 Not a randomised or quasi-randomised controlled trial.
Blajchman 2004 Narrative, non-systematic literature review.
Calfee 2002 None of the four study arms involved a two-step skin preparation process
Choudhuri 1990 Comparison of two one-step processes; alcohol swab compared with iodine swab
de Korte 2006 Single arm study evaluating a double-swab isopropyl alcohol disinfection process
Follea 1997 Examined techniques for quantifying bacterial reduction by comparing a three-step process with no skin
disinfection
Goldman 1997 Abstract only available and it was unclear how patients where allocated to groups. Though this was not likely
to have been randomised or quasi-randomised because one group was treated in a particular way on the basis
that they were allergic to iodine. Also there was no one-step, alcohol-only skin preparation group
Kiyoyama 2009 Not a randomised or quasi-randomised controlled trial. Two independent groups were considered; one
group from an inpatient ward was treated with isopropyl alcohol + povidone-iodine and the other from an
emergency department was treated with isopropyl alcohol alone
Lee 2002 Not a randomised or quasi-randomised controlled trial. Comparison of two two-step processes in consecutive
time periods. Cetrimide/ chlorhexidine solution + isopropyl alcohol compared with povidone-iodine +
isopropyl alcohol
Little 1999 Povidone-iodine was compared with iodine tincture, i.e. not a comparison of a one-step with a two-step skin
preparation
McDonald 2006 An uncontrolled before and after evaluation of a two-step process involving isopropyl alcohol + tincture of
iodine
McDonald 2010 Not a randomised or quasi-randomised controlled trial.
Mimoz 1999 Povidone-iodine compared with chlorhexidine, i.e. not a comparison of a one-step with a two-step skin
preparation
Pleasant 1994 Only available in abstract form; no information to suggest this was a randomised controlled trial; attempts
to contact the authors were unsuccessful
Ramirez-Arcos 2010 Not a randomised or quasi-randomised controlled trial.
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(Continued)
Schifman 1993 Comparison of two two-step processes, namely, isopropyl alcohol pads + povidone-iodine swabs compared
with isopropyl alcohol/acetone scrub + povidone-iodine dispenser
Shahar 1990 Not a randomised or quasi-randomised controlled trial; the venepuncture site was cleansed with a two-step
process after which a culture was taken, at a later time point the venepuncture site was cleansed with a one-
step process after which a culture was taken. The two samples were collected from the same person but it
is not clear from the report if the two venepuncture sites were different, if there was a possibility of cross
contamination between sites and what time period separated the sampling process
Sutton 1999 Isopropyl alcohol (IPA) compared with no IPA skin preparation, i.e. not a comparison of a one-step with a
two-step skin preparation
Suwanpimolkul 2008 Chlorhexidine in alcohol compared with povidone-iodine, i.e. not a comparison of a one-step with a two-
step skin preparation
Trautner 2002 Chlorhexidine gluconate compared with iodine tincture, i.e. not a comparison of a one-step with a two-step
skin preparation
Wendel 2002 Narrative, non-systematic literature review.
Wong 2004 An uncontrolled before and after study of a one-step process involving chlorhexidine gluconate
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Search methods for the original review - 2009
We searched the following databases:
• Cochrane Wounds Group Specialised Register (Searched March 10 2009);
• The Cochrane Central Register of Controlled Trials (CENTRAL) -The Cochrane Library 2009, Issue 1;
• Ovid MEDLINE - 1950 to February Week 4 2009;
• Ovid EMBASE - 1980 to 2009 Week 9;
• EBSCO CINAHL - 1982 to February Week 4 2009.
The Cochrane Central Register of Controlled Trials (CENTRAL) was searched using the following strategy:
#1 MeSH descriptor Blood Specimen Collection explode all trees
#2 MeSH descriptor Blood Transfusion explode all trees
#3 MeSH descriptor Blood Donors explode all trees
#4 (blood NEXT collection*) or (blood NEXT donor*) or (blood NEXT donation*):ti,ab,kw
#5 (collection NEAR/1 blood) or (donation NEAR/1 blood):ti,ab,kw
#6 ven*puncture NEXT site*:ti,ab,kw
#7 (#1 OR #2 OR #3 OR #4 OR #5 OR #6)
#8 MeSH descriptor Antisepsis explode all trees
#9 MeSH descriptor Anti-Infective Agents, Local explode all trees
#10 MeSH descriptor Iodine Compounds explode all trees
#11 MeSH descriptor Povidone-Iodine explode all trees
#12 MeSH descriptor Alcohols explode all trees
#13 MeSH descriptor Disinfectants explode all trees
#14 MeSH descriptor Disinfection explode all trees
#15 skin NEXT preparation:ti,ab,kw
#16 disinfect*:ti,ab,kw
#17 (“alcohol” or “alcohols” or iodine or povidone-iodine or chlorhexidine):ti,ab,kw
#18 (#8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17)
#19 (#7 AND #18)
The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in Appendix 2, Appendix 3 and
Appendix 4 respectively. TheOvidMEDLINE search was combined with the Cochrane Highly Sensitive Search Strategy for identifying
randomised trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision) (Lefebvre 2009). The Ovid EMBASE
and EBSCO CINAHL searches were combined with the trial filters developed by the Scottish Intercollegiate Guidelines Network
(SIGN 2009). There was no restriction on the basis of date or language of publication.
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Appendix 2. Ovid MEDLINE search strategy
1 exp Blood Specimen Collection/
2 exp Blood Transfusion/
3 exp Blood Donors/
4 (blood collection$ or blood donor$ or blood donation$).ti,ab.
5 ((collect$ adj1 blood) or (donat$ adj1 blood)).ti,ab.
6 ven?puncture site$.ti,ab.
7 or/1-6
8 exp Antisepsis/
9 exp Anti-Infective Agents, Local/
10 exp Iodine Compounds/
11 exp Povidone-Iodine/
12 exp Alcohols/
13 exp Disinfectants/
14 exp Disinfection/
15 skin preparation.ti,ab.
16 disinfect$.ti,ab.
17 (alcohol$1 or iodine or povidone-iodine or chlorhexidine).ti,ab.
18 or/8-17
19 7 and 18
Appendix 3. Ovid EMBASE search strategy
1 exp Blood Sampling/
2 exp Blood Transfusion/
3 exp Blood Donor/
4 (blood collection$ or blood donor$ or blood donation$).ti,ab.
5 ((collect$ adj1 blood) or (donat$ adj1 blood)).ti,ab.
6 exp Vein Puncture/
7 ven?puncture site$.ti,ab.
8 or/1-7
9 exp Antisepsis/
10 exp Topical Antiinfective Agent/
11 exp Iodine/
12 exp Povidone Iodine/
13 exp Chlorhexidine/
14 exp Alcohol/
15 exp Disinfectant Agent/
16 exp Disinfection/
17 skin preparation.ti,ab.
18 disinfect$.ti,ab.
19 (alcohol$1 or iodine or povidone-iodine or chlorhexidine).ti,ab.
20 or/9-19
21 8 and 20
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Appendix 4. EBSCO CINAHL search strategy
S19 S9 and S18
S18 S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17
S17 TI ( alcohol or alcohols or iodine or povidone-iodine or chlorhexidine ) or AB ( alcohol or alcohols or iodine or povidone-iodine
or chlorhexidine )
S16 TI disinfect* or AB disinfect*
S15 TI skin preparation or AB skin preparation
S14 (MH “Disinfectants”)
S13 (MH “Alcohols+”)
S12 (MH “Povidone-Iodine”)
S11 (MH “Iodine”)
S10 (MH “Antiinfective Agents, Local+”)
S9 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8
S8 TI venepuncture site* or AB venepuncture site*
S7 (MH “Venipuncture+”)
S6 TI blood donation* or AB blood donation*
S5 TI blood donor* or AB blood donor*
S4 TI blood collection* or AB blood collection*
S3 (MH “Blood Donors”)
S2 (MH “Blood Transfusion+”)
S1 (MH “Blood Specimen Collection+”)
Appendix 5. Criteria for a judgment of ’yes’ for the sources of bias
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
Insufficient information about the sequence generation process to permit judgement of low or high risk of bias.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
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High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: using an open random allocation schedule (e.g. a list of randomnumbers); assignment envelopes were usedwithout appropriate
safeguards (e.g. if envelopes were unsealed or non opaque or not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure.
Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not
described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described,
but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Any one of the following.
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing
bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a
clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
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High risk of bias
Any one of the following.
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce
clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes enough to induce clinically relevant bias in observed effect size.
• ‘As-treated’ analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Any one of the following.
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated,
no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Any of the following.
• The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of interest in the
review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were pre-specified (convincing text of this nature may be uncommon)
High risk of bias
Any one of the following.
• Not all of the study’s pre-specified primary outcomes have been reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that
were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as
an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
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High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• had extreme baseline imbalance; or
• has been claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
Appendix 6. Protocol for the review ready for submission March 2009
The protocol for this review was completed and ready for submission in March 2009, the review being completed and ready for
submission in April 2009. As the protocol has not been previously published in the Cochrane Library it is appended below in full.
Skin preparation with alcohol versus alcohol followed by any antiseptic for preventing bacteraemia or
contamination of blood for transfusion.
Protocol information
Authors
Joan Webster1, Sally EM Bell-Syer2, Ruth Foxlee2
1Centre for Clinical Nursing, Royal Brisbane and Women’s Hospital, Herston, Australia
2Department of Health Sciences, University of York, York, UK
Background
Complications associated with the infusion of blood and blood-related products have reduced in recent years, due to considerable
advances in detecting transfusion-related viral pathogens, such as human immunodeficiency virus (HIV) and hepatitis C and B virus
(HCV and HBV). In contrast, bacteraemia, resulting from bacterial contamination of blood products continues to be an ongoing
problem (Sandler 2003; Wagner 2004). Exogenous contamination may occur at any point during collection and storage (McDonald
2001). One of these sources is thought to be the donors arm, as a result of inadequate skin disinfection (de Korte 2006; McDonald
2006).
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Description of the condition
Bacteraemia, or the presence of bacteria in the blood, is a potentially fatal condition and associated with high rates of morbidity
(Hakim 2007; Sligl 2006). Microorganisms may enter the blood stream through almost any organ (for example the lungs following
pneumonia); through a surgical site, or via an implanted device such as an intravenous catheter. Prognosis is related to the virulence
of the infective organism, severity of the sepsis at diagnosis and the underlying health of the patient (Herchline 1997). Although
the aetiology of bacteraemia is often difficult to identify, transfusion-transmitted infection is a rare cause. The incidence of bacterial
transmission through donated blood is estimated at between 1 per 100,000 and 1 per 1,000,000 units for packed red blood cells and
between 1 per 900 and 1 per 100,000 units for platelets (Walther-Wenke 2008). Fatalities are associated with 1 in 8,000,000 red cell
units and 1 in 50,000 to 500,000 white cell units (Wagner 2004). Further reduction of these rates depends on ensuring that blood for
transfusion is free of contaminants. One way of achieving this is through careful preparation and disinfection of the arm of the blood
donor.
Description of the intervention
There is no standard method for cleansing the site on the blood donor’s skin from which the blood will be taken (generally the cubital
fossa, or the inner aspect of the elbow). However, alcohol, followed by an application of povidone iodine has been traditionally used
(Shahar 1990; Kiyoyama 2009). Consequently, the interventions of interest for this review are skin cleansing with alcohol (usually
70% isopropyl alcohol) for skin preparation in a one-step process, compared with a two-step process involving alcohol followed by
povidone iodine or other antiseptic solution. Antiseptics are antimicrobial substances that are applied to living tissue or skin to reduce
the possibility of infection, sepsis or putrefaction. They should generally be distinguished from antibiotics that destroy bacteria within
the body, and from disinfectants, which destroy microorganisms found on non-living objects. Alcohol is widely used for venepuncture
and is available, from a number of manufacturers as easy-to-use disinfection wipes. Isopropyl alcohol is a flammable, colourless liquid;
also know as 2-propanol (Safety (MSDS) data for 2-propanol accessed 3 March 2009).
How the intervention might work
Alcohol kills most bacteria and fungi by acting on lipid and protein components of the cell. It is less effective against viruses (Adams
2007). Isopropyl alcohol has some advantages over other products because it requires a shorter contact time for disinfection. For
example some two-stage disinfection procedures take up to two minutes to perform, which is considered too long for some blood bank
services (McDonald 2006). Antiseptics are toxic to living tissues as well as bacterial cells, some antiseptics are true germicides, capable
of destroying microbes (bacteriocidal), whilst others are bacteriostatic and only prevent or inhibit their growth (Morgan 1993).
Why it is important to do this review
Although a range of antiseptics have been used to disinfect the donor arm, a two-step process, including alcohol and iodine is widely
used. The effectiveness of this process, and other forms of disinfection have been evaluated in a number of studies by measuring the
microbial load on the donor arm (Cid 2003; Follea 1997; Goldman 1997; McDonald 2001; Wong 2004) and any contamination of
platelet concentrates de Korte 2006; Lee 2002). Despite this, it remains unclear if isopropyl alcohol alone is as effective as alcohol plus
povidone iodine in preventing blood product contamination or bacteraemia. This review question was brought to us by the World
Health Organisation (WHO) and a scoping search did not identify any existing systematic review which had previously addressed this
question.
Objectives
To assess the effects of cleansing the donor arm with alcohol in a one-step regimen compared with a two-step regimen including alcohol
followed by any other antiseptic to prevent donor blood contamination or recipient bacteraemia.
Methods
Criteria for considering studies for this review
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Types of studies
All randomised controlled trials (RCTs) comparing a one-step alcohol regimen with any two-step regimen that includes alcohol followed
by another antiseptic for pre-venepuncture skin cleansing will be considered. Cluster randomised trials and crossover trials will also be
eligible for inclusion. Quasi randomised trials will be considered in the absence of RCTs.
Types of participants
Studies enrolling people of any age and in any setting, having venepuncture and blood collection will be eligible, irrespective of whether
the venepuncture was for the purpose of blood donation. Studies should also include follow up from the recipients of the donated
blood in order to measure outcomes occurring in the recipient.
Types of interventions
Studies which compare a one-step donor skin cleansing with alcohol (any concentration or application method) with a two-step method
which involves alcohol (any strength or application method) followed by any other antiseptic (any concentration or application method)
will be eligible.
Types of outcome measures
At least one of the primary outcomes must be reported for inclusion of the review.
Primary outcomes
• Bacteraemia in the blood recipient (the presence of bacteria in the blood stream) as measured by blood culture.
• Blood product contamination (blood products include whole blood, platelets, red blood cells or any other product derived from
the blood collection) at any time between collection and transfusion as detected most commonly by blood culture.
Proxy outcome measures, such as skin contamination or skin colonisation, will not be considered.
Secondary outcomes
• Death of the blood recipient, attributed to the transfusion.
• Any adverse effects in the blood recipient associated with the transfusion. This may include sepsis (a grouping of signs such as
fever, chills, or hypotension), septic shock (severe disturbances of temperature, respiration, heart rate or white blood cell count) or
multiple organ dysfunction syndrome (altered organ function in a severely ill patient that requires medical intervention to prevent
death).
Search methods for identification of studies
Electronic searches
The following databases will be searched:
Cochrane Wounds Group Specialised Register;
The Cochrane Central Register of Controlled Trials (CENTRAL) latest issue;
Ovid MEDLINE - 1950 to Current;
Ovid EMBASE - 1980 to Current;
EBSCO CINAHL - 1982 to Current.
The Cochrane Central Register of Controlled Trials (CENTRAL) will also be searched (latest issue) using the following strategy:
#1 MeSH descriptor Blood Specimen Collection explode all trees
#2 MeSH descriptor Blood Transfusion, Autologous explode all trees
#3 MeSH descriptor Blood Donors explode all trees
#4 (blood NEXT collection*) or (blood NEXT donor*) or (blood NEXT donation*):ti,ab,kw
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#5 ven*puncture:ti,ab,kw
#6 (#1 OR #2 OR #3 OR #4 OR #5)
#7 MeSH descriptor Antisepsis explode all trees
#8 MeSH descriptor Anti-Infective Agents, Local explode all trees
#9 MeSH descriptor Iodine Compounds explode all trees
#10 MeSH descriptor Povidone-Iodine explode all trees
#11 MeSH descriptor Alcohols explode all trees
#12 MeSH descriptor Disinfectants explode all trees
#13 MeSH descriptor Disinfection explode all trees
#14 skin NEXT preparation:ti,ab,kw
#15 skin NEXT disinfection:ti,ab,kw
#16 (“alcohol” or “alcohols” or iodine or povidone-iodine or chlorhexidine):ti,ab,kw
#17 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16)
#18 (#6 AND #17)
This strategy will be adapted were appropriate for the other databases. The OvidMEDLINE searchwill be combined with theCochrane
Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity- and precision-maximizing version (2008
revision) (Lefebvre 2009). The Ovid EMBASE and EBSCO CINAHL searches will be combined with the trial filters developed by the
Scottish Intercollegiate Guidelines Network (SIGN 2009). There was no restriction on the basis of date or language of publication.
Searching other resources
Reference lists of potentially useful articles will also be searched.
Data collection and analysis
Selection of studies
Titles and abstracts identified through the search process will be independently reviewed by two review authors. Full reports of all
potentially relevant trials will be retrieved for further assessment of eligibility based on the inclusion criteria. Differences of opinion
will be settled by consensus or referral to a third review author. There will be no blinding of authorship.
Data extraction and management
Two review authors will independently assess the quality of eligible trials, using the quality assessment criteria outlined below. Disagree-
ments between review authors will be resolved by consensus or referral to a third review author.We will contact investigators of included
trials to resolve any ambiguities. Whilst data from duplicate publications will be included only once, all publications pertaining to a
single study will be retrieved and used to enable full data extraction and quality assessment.
We will extract the following data, where possible:
• details of the trial/study (first author, year of publication, journal, publication status, period);
• setting and country of study;
• source of funding;
• inclusion and exclusion criteria;
• baseline characteristics of participants (age, sex);
• aspects of morbidity of the blood recipients, e.g. predictors of susceptibility to bacteraemia;
• number of participants in each arm of the trial;
• description of intervention (type, duration);
• description of control intervention (type, duration);
• details and duration of follow up;
• primary and secondary outcomes (by group);
• design / methodological quality data as per risk of bias criteria;
• unit of randomisation (where relevant);
• unit of analysis;
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• results and primary statistical analysis.
Assessment of risk of bias in included studies
Two authors will independently assess each included study using the Cochrane Collaboration tool for assessing risk of bias Higgins
2009a. This tool addresses six specific domains, namely sequence generation, allocation concealment, blinding, incomplete outcome
data, selective outcome reporting and other issues (e.g. co-interventions)(see Appendix 5 for details of criteria on which the judgement
will be based). Blinding and completeness of outcome data will be assessed for each outcome separately. We will complete a risk of bias
table for each eligible study. We will discuss any disagreement amongst all authors to achieve a consensus.
We will present assessment of risk of bias using a ’risk of bias summary figure’, which presents all of the judgments in a cross-tabulation
of study by entry. This display of internal validity indicates the weight the reader may give the results of each study.
Measures of treatment effect
For individual trials, effect measures for categorical outcomes will include relative risk (RR) with its 95% confidence interval (CI). For
statistically significant effects, number needed to treat (NNT), or number needed to harm (NNH), will be calculated. For continuous
outcomes, the effect measure will be mean difference (MD) or, if the scale of measurement differs across trials, standardized mean
difference (SMD), each with its 95% CI. For any meta-analyses (see below), for categorical outcomes the typical estimates of RR with
their 95% CI will be calculated; and for continuous outcomes the weighted mean difference (WMD) or a summary estimate for SMD,
each with its 95% CI, will be calculated.
Data will be analysed using The Cochrane Collaboration’s Review Manager 5 software.
Dealing with missing data
If some outcome data remain missing despite our attempts to obtain complete outcome data from authors, we will perform an available-
case analysis, based on the numbers of patients for whom outcome data are known. If standard deviations are missing, we will impute
them from other studies or, where possible, compute them from standard errors using the formula SD = SE x ?N , where these are
available (Higgins 2009a).
Assessment of heterogeneity
Heterogeneity will be assessed visually and by using the chi-squared statistic with significance being set at p < 0.10. In addition, the
degree of heterogeneity will be investigated by calculating the I2 statistic Higgins 2009a. If evidence of significant heterogeneity is
identified (>50%), we will explore potential causes and a random-effects approach to the analysis will be used if a meta analysis is
appropriate.
Assessment of reporting biases
Reporting bias will be assessed using guidelines in Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2009a).
Data synthesis
Where appropriate, results of comparable trials will be pooled using a fixed-effect model and the pooled estimate together with its 95%
CI will be reported. We will conduct a narrative review of eligible studies where statistical synthesis of data from more than one study
is not possible or considered not appropriate.
Subgroup analysis and investigation of heterogeneity
We plan to analyse potential sources of heterogeneity using the following subgroup analysis - concealment of allocation (adequate versus
not reported).
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Sensitivity analysis
We will perform a sensitivity analysis to explore the effect of concealment of allocation (adequate versus not reported).
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Appendices
1 Criteria for a judgment of ’yes’ for the sources of bias
1. Was the allocation sequence randomly generated?
Yes, low risk of bias
A random (unpredictable) assignment sequence.
Examples of adequate methods of sequence generation are computer-generated random sequence, coin toss (for studies with two
groups), rolling a dice (for studies with two or more groups), drawing of balls of different colours, dealing previously shuffled cards.
No, high risk of bias
- Quasi-randomised approach: Examples of inadequate methods are: alternation, birth date, social insurance/security number, date in
which they are invited to participate in the study, and hospital registration number
- Non-random approaches: Allocation by judgement of the clinician; by preference of the participant; based on the results of a laboratory
test or a series of tests; by availability of the intervention.
Unclear
Insufficient information about the sequence generation process to permit judgement
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2. Was the treatment allocation adequately concealed?
Yes, low risk of bias
Assignment must be generated independently by a person not responsible for determining the eligibility of the participants. This
person has no information about the persons included in the trial and has no influence on the assignment sequence or on the
decision about whether the person is eligible to enter the trial. Examples of adequate methods of allocation concealment are: Central
allocation, including telephone,web-based, andpharmacy controlled,randomization; sequentially numbereddrug containers of identical
appearance; sequentially numbered, opaque, sealed envelopes.
No, high risk of bias
Examples of inadequate methods of allocation concealment are: alternatemedical record numbers, unsealed envelopes; date of birth; case
record number; alternation or rotation; an open list of random numbers any information in the study that indicated that investigators
or participants could influence the intervention group.
Unclear
Randomisation stated but no information on method of allocation used is available.
3. Blinding was knowledge of the allocated interventions adequately prevented during the study?
Was the participant blinded to the intervention?
Yes, low risk of bias
The treatment and control groups are indistinguishable for the participants or if the participant was described as blinded and the
method of blinding was described.
No, high risk of bias
- Blinding of study participants attempted, but likely that the blinding could have been broken; participants were not blinded, and
the nonblinding of others likely to introduce bias.
Unclear
Was the care provider blinded to the intervention?
Yes, low risk of bias
The treatment and control groups are indistinguishable for the care/treatment providers or if the care provider was described as blinded
and the method of blinding was described.
No, high risk of bias
Blinding of care/treatment providers attempted, but likely that the blinding could have been broken; care/treatment providers were
not blinded, and the nonblinding of others likely to introduce bias.
Unclear
Was the outcome assessor blinded to the intervention?
Yes, low risk of bias
Adequacy of blinding should be assessed for the primary outcomes. The outcome assessor was described as blinded and the method
of blinding was described.
No, high risk of bias
No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding
Unclear
4. Were incomplete outcome data adequately addressed?
Was the drop-out rate described and acceptable?
The number of participants who were included in the study but did not complete the observation period or were not included in the
analysis must be described and reasons given.
Yes, low risk of bias
If the percentage of withdrawals and drop-outs does not exceed 20% for short-term follow-up and 30% for long-term follow-up and
does not lead to substantial bias. (N.B. these percentages are arbitrary, not supported by literature);
No missing outcome data;
Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias);
Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups;
Missing data have been imputed using appropriate methods.
No, high risk of bias
Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data
across intervention groups;
Unclear
Were all randomised participants analysed in the group to which they were allocated? (ITT analysis)
25Skin preparation with alcohol versus alcohol followed by any antiseptic for preventing bacteraemia or contamination of blood for
transfusion (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Yes, low risk of bias
Specifically reported by authors that ITT was undertaken and this was confirmed on study assessment, or not stated but evident from
study assessment that all randomised participants are reported/analysed in the group they were allocated to for the most important
time point of outcome measurement (minus missing values) irrespective of non-compliance and co-interventions.
No, high risk of bias
Lack of ITT confirmed on study assessment (patients who were randomised were not included in the analysis because they did not
receive the study intervention, they withdrew from the study or were not included because of protocol violation) regardless of whether
ITT reported or not
‘As-treated’ analysis done with substantial departure of the intervention received from that assigned at randomisation; potentially
inappropriate application of simple imputation.
Unclear
Described as ITT analysis, but unable to confirm on study assessment, or not reported and unable to confirm by study assessment.
5. Are reports of the study free of suggestion of selective outcome reporting?
Yes, low risk of bias
If all the results from all pre-specified outcomes have been adequately reported in the published report of the trial. This information is
either obtained by comparing the protocol and the final trial report, or in the absence of the protocol, assessing that the published report
includes enough information to make this judgment. Alternatively a judgement could be made if the trial report lists the outcomes of
interest in the methods of the trial and then reports all these outcomes in the results section of the trial report.
No, high risk of bias
Not all of the study’s pre-specified primary outcomes have been reported;
One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not
prespecified;
One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an
unexpected adverse effect);
One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis;
The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
6. Other sources of potential bias:
Were co-interventions avoided or similar?
There were no co-interventions or there were co-interventions but they were similar between the treatment and control groups.
Was the compliance acceptable in all groups?
The review author determines if the compliance with the interventions is acceptable, based on the reported intensity, duration, number
and frequency of sessions for both the treatment intervention and control intervention(s). For example, ultrasound treatment is usually
administered over several sessions; therefore it is necessary to assess how many sessions each participant attended or if participants
completed the course of an oral drug therapy. For single-session interventions (for example: surgery), this item is irrelevant.
WH A T ’ S N E W
Last assessed as up-to-date: 30 January 2011.
Date Event Description
30 August 2011 Amended republish, update affiliations, risk of bias terminology
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H I S T O R Y
Review first published: Issue 3, 2009
Date Event Description
2 February 2011 New search has been performed New search, no new studies identified for inclusion, 3 studies added to the
Table of Excluded studies (Benjamin 2010; McDonald 2010; Ramirez-Arcos
2010). The review conclusions remain unchanged.
C O N T R I B U T I O N S O F A U T H O R S
Joan Webster: designed the review, checked the search results and all papers retrieved in full, wrote the review draft, responded to the
peer referee feedback, made an intellectual contribution to the review and approved the final review prior to submission, updated the
review. Guarantor of the review.
Sally Bell-Syer: coordinated the review, edited the review draft, responded to the peer referee feedback, made an intellectual contribution
to the review and approved the final review and review update prior to submission.
Ruth Foxlee: designed the search strategy, conducted the literature searches, retrieved papers, checked all papers retrieved in full. Edited
the search methods section and responded to the peer referee feedback and approved the final review and updated review prior to
submission.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Nil
N O T E S
This rapid response review was undertaken at the request of the World Health Organisation (WHO). This organisation framed the
review question but they did not provide funding or influence its publication.
The protocol for this review was completed and ready for submission in March 2009, the review being completed and ready for
submission in April 2009. As the protocol has not been previously published in the Cochrane Library it is appended to this review in
the interests of transparency (Appendix 6).
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Blood Donors; ∗Skin [microbiology]; Anti-Infective Agents, Local [∗administration & dosage]; Bacteremia [∗prevention & control];
Blood Transfusion; Ethanol [∗administration & dosage]; Randomized Controlled Trials as Topic
MeSH check words
Humans
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